$BASE
Couchbase, Inc.

2022 Q2 Form 10-Q Financial Statement

#000184502222000057 Filed on June 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2022
Revenue $34.85M $35.06M $123.5M
YoY Change 24.68% 19.61%
Cost Of Revenue $4.651M $4.128M $14.78M
YoY Change 37.12% 27.24%
Gross Profit $30.20M $30.94M $108.8M
YoY Change 22.96% 18.65%
Gross Profit Margin 86.66% 88.23% 88.04%
Selling, General & Admin $34.77M $30.23M $113.4M
YoY Change 33.06% 32.22%
% of Gross Profit 115.12% 97.72% 104.25%
Research & Development $14.42M $13.37M $51.64M
YoY Change 14.99% 32.41%
% of Gross Profit 47.75% 43.22% 47.48%
Depreciation & Amortization $739.0K $710.0K $2.824M
YoY Change 4.38% -45.3% 40.78%
% of Gross Profit 2.45% 2.3% 2.6%
Operating Expenses $49.19M $43.60M $165.0M
YoY Change 27.2% 32.28%
Operating Profit -$18.99M -$12.67M -$56.26M
YoY Change 34.58% 70.07%
Interest Expense $25.00K -$26.40K $656.0K
YoY Change -89.8% -90.59%
% of Operating Profit
Other Income/Expense, Net -$556.0K -$255.6K -$300.0K
YoY Change -761.9% -127.0%
Pretax Income -$19.57M -$12.95M -$57.21M
YoY Change 37.13% 46.93%
Income Tax $300.0K $286.0K $1.015M
% Of Pretax Income
Net Earnings -$19.83M -$13.24M -$58.23M
YoY Change 35.86% 45.63%
Net Earnings / Revenue -56.91% -37.75% -47.13%
Basic Earnings Per Share -$0.45 -$2.37
Diluted Earnings Per Share -$0.45 -$303.0K -$2.37
COMMON SHARES
Basic Shares Outstanding 44.27M shares 44.17M shares 25.78M shares
Diluted Shares Outstanding 44.27M shares 25.78M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $201.1M $206.0M $206.0M
YoY Change 276.64% 262.32%
Cash & Equivalents $47.67M $95.69M $95.69M
Short-Term Investments $153.4M $110.3M $110.3M
Other Short-Term Assets $1.418M $1.744M $20.34M
YoY Change -88.57% 555.64% 88.32%
Inventory
Prepaid Expenses $3.817M $4.518M
Receivables $24.62M $36.70M $36.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $245.3M $263.0M $263.0M
YoY Change 194.68% 154.0% 154.0%
LONG-TERM ASSETS
Property, Plant & Equipment $4.341M $4.288M $4.288M
YoY Change -25.17% -34.09% -34.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.453M $1.219M $9.462M
YoY Change -83.36% -44.57% 32.52%
Total Long-Term Assets $21.73M $13.75M $13.75M
YoY Change 49.49% 0.76% 0.76%
TOTAL ASSETS
Total Short-Term Assets $245.3M $263.0M $263.0M
Total Long-Term Assets $21.73M $13.75M $13.75M
Total Assets $267.0M $276.7M $276.7M
YoY Change 173.09% 136.15% 136.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.640M $1.923M $1.923M
YoY Change -22.92% -20.8% -20.8%
Accrued Expenses $2.946M $3.231M $15.46M
YoY Change -68.16% -22.22% 20.54%
Deferred Revenue $68.47M $69.01M
YoY Change 20.71%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $84.79M $90.31M $90.31M
YoY Change 33.18% 23.95% 23.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $0.00 $507.0K $3.220M
YoY Change -100.0% -62.67% -45.42%
Total Long-Term Liabilities $0.00 $507.0K $3.220M
YoY Change -100.0% -98.07% -89.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $84.79M $90.31M $90.31M
Total Long-Term Liabilities $0.00 $507.0K $3.220M
Total Liabilities $92.71M $93.53M $93.53M
YoY Change -3.04% -9.82% -9.82%
SHAREHOLDERS EQUITY
Retained Earnings -$361.8M -$342.0M
YoY Change 20.52%
Common Stock $0.00 $0.00
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $174.3M $183.2M $183.2M
YoY Change
Total Liabilities & Shareholders Equity $267.0M $276.7M $276.7M
YoY Change 173.09% 136.15% 136.15%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2022
OPERATING ACTIVITIES
Net Income -$19.83M -$13.24M -$58.23M
YoY Change 35.86% 45.63%
Depreciation, Depletion And Amortization $739.0K $710.0K $2.824M
YoY Change 4.38% -45.3% 40.78%
Cash From Operating Activities -$8.607M -$2.652M -$41.57M
YoY Change 169.9% -92.63% 6.12%
INVESTING ACTIVITIES
Capital Expenditures $799.0K -$5.000K $819.0K
YoY Change 247.39% -99.81% -70.95%
Acquisitions
YoY Change
Other Investing Activities -$44.03M -$44.40M -$91.21M
YoY Change -1371.07% 92.57% 365.53%
Cash From Investing Activities -$44.83M -$44.41M -$92.03M
YoY Change -1486.18% 73.15% 310.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.139M 1.562M $192.4M
YoY Change 76637.5% -98.06% 139.02%
NET CHANGE
Cash From Operating Activities -$8.607M -2.652M -$41.57M
Cash From Investing Activities -$44.83M -44.41M -$92.03M
Cash From Financing Activities $6.139M 1.562M $192.4M
Net Change In Cash -$48.02M -45.50M $58.39M
YoY Change -102261.7% -341.25% 206.14%
FREE CASH FLOW
Cash From Operating Activities -$8.607M -$2.652M -$41.57M
Capital Expenditures $799.0K -$5.000K $819.0K
Free Cash Flow -$9.406M -$2.647M -$42.39M
YoY Change 175.11% -92.07% 0.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001845022
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 us-gaap Assets Current
AssetsCurrent
262992000 USD
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-40601
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
Couchbase, Inc.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3576987
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
3250 Olcott Street
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
CY2022Q2 dei City Area Code
CityAreaCode
650
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
417-7500
CY2022Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.00001 per share
CY2022Q2 dei Trading Symbol
TradingSymbol
BASE
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44551077 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47672000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95688000 USD
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
153409000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
110266000 USD
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24622000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36696000 USD
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11548000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11783000 USD
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8014000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8559000 USD
CY2022Q2 us-gaap Assets Current
AssetsCurrent
245265000 USD
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4341000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4288000 USD
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7668000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2022Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
8267000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
8243000 USD
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1453000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1219000 USD
CY2022Q2 us-gaap Assets
Assets
266994000 USD
CY2022Q1 us-gaap Assets
Assets
276742000 USD
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2640000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1923000 USD
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8025000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16143000 USD
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2946000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3231000 USD
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2717000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
68466000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
69010000 USD
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
84794000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
90307000 USD
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5627000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2289000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2713000 USD
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
507000 USD
CY2022Q2 us-gaap Liabilities
Liabilities
92710000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
93527000 USD
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44537296 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44537296 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43847484 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43847484 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
536981000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
525392000 USD
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-881000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-195000 USD
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-361816000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-341982000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
174284000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
183215000 USD
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
266994000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
276742000 USD
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34853000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27955000 USD
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
4651000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
3392000 USD
CY2022Q2 us-gaap Gross Profit
GrossProfit
30202000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
24563000 USD
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14421000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12541000 USD
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26843000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20634000 USD
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7926000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5497000 USD
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
49190000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
38672000 USD
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18988000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14109000 USD
CY2022Q2 us-gaap Interest Expense
InterestExpense
25000 USD
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19834000 USD
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19834000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
245000 USD
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-556000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19569000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14270000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
265000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
329000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14599000 USD
CY2022Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2021Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1479000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
183215000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16078000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16078000 USD
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.55
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44265000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44265000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6302000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6302000 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14599000 USD
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-686000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000 USD
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20520000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14601000 USD
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2614000 USD
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3525000 USD
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5450000 USD
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-686000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19834000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
174284000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-246342000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1447000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1829000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14599000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-257667000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14599000 USD
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
739000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
708000 USD
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5450000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1829000 USD
CY2022Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
4009000 USD
CY2021Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2958000 USD
CY2022Q2 base Non Cash Lease Expense
NonCashLeaseExpense
648000 USD
CY2021Q2 base Non Cash Lease Expense
NonCashLeaseExpense
0 USD
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-974000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
75000 USD
CY2022Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
198000 USD
CY2021Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
34000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11781000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18557000 USD
CY2022Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-3798000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-2718000 USD
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-312000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1898000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
731000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1021000 USD
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8112000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3274000 USD
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-71000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-668000 USD
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-666000 USD
CY2021Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-968000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5064000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8607000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3189000 USD
CY2022Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
53630000 USD
CY2021Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1726000 USD
CY2022Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
9600000 USD
CY2021Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
5190000 USD
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
799000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
230000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44829000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3234000 USD
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2614000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1447000 USD
CY2022Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3525000 USD
CY2021Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 USD
CY2022Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1439000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6139000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8000 USD
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-719000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48016000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96231000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37840000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48215000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37887000 USD
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47672000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37344000 USD
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
543000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
543000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48215000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37887000 USD
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
275000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
271000 USD
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
25000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
246000 USD
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-686000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-3000 USD
CY2022Q2 base Change In Deferred Offering Costs Included In Accounts Payable And Other Accrued Liabilities
ChangeInDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedLiabilities
0 USD
CY2021Q2 base Change In Deferred Offering Costs Included In Accounts Payable And Other Accrued Liabilities
ChangeInDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedLiabilities
102000 USD
CY2022Q2 base Increase Decrease In Purchases Of Property And Equipment Included In Accounts Payable And Other Accrued Liabilities
IncreaseDecreaseInPurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherAccruedLiabilities
-9000 USD
CY2021Q2 base Increase Decrease In Purchases Of Property And Equipment Included In Accounts Payable And Other Accrued Liabilities
IncreaseDecreaseInPurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherAccruedLiabilities
-227000 USD
CY2021Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
214900000 USD
CY2021Q3 base Sale Of Stock Shares Conversion Of Convertible Securities
SaleOfStockSharesConversionOfConvertibleSecurities
26710600 shares
CY2021Q3 base Sale Of Stock Shares Conversion Of Convertible Securities Dividends
SaleOfStockSharesConversionOfConvertibleSecuritiesDividends
640387 shares
CY2022Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year.</span></div>
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices (“SSP”) for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of the Company's common stock prior to the IPO in July 2021, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.</span></div>
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6700000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7500000 USD
CY2022Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
800000 USD
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
42651000 USD
CY2022Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
42651000 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
154290000 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
881000 USD
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
153409000 USD
CY2022Q2 base Cash Equivalents And Short Term Investments Amortized Cost
CashEquivalentsAndShortTermInvestmentsAmortizedCost
196941000 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
881000 USD
CY2022Q2 base Cash Cash Equivalents And Short Term Investments Estimated Fair Value
CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue
196060000 USD
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
86505000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
86505000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
110462000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
196000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
110266000 USD
CY2022Q1 base Cash Equivalents And Short Term Investments Amortized Cost
CashEquivalentsAndShortTermInvestmentsAmortizedCost
196967000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
196000 USD
CY2022Q1 base Cash Cash Equivalents And Short Term Investments Estimated Fair Value
CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue
196771000 USD
CY2021Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 USD
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 USD
CY2022Q2 base Short Term Investments Contractual Maturity In One Year
ShortTermInvestmentsContractualMaturityInOneYear
123200000 USD
CY2022Q2 base Short Term Investments Contractual Maturity Greater Than One Year
ShortTermInvestmentsContractualMaturityGreaterThanOneYear
30200000 USD
CY2022Q1 base Short Term Investments Contractual Maturity In One Year
ShortTermInvestmentsContractualMaturityInOneYear
108300000 USD
CY2022Q1 base Short Term Investments Contractual Maturity Greater Than One Year
ShortTermInvestmentsContractualMaturityGreaterThanOneYear
2000000 USD
CY2022Q2 base Number Of Short Term Investments In Unrealized Loss Position
NumberOfShortTermInvestmentsInUnrealizedLossPosition
32 investment
CY2022Q2 base Short Term Investments Estimated Fair Value
ShortTermInvestmentsEstimatedFairValue
118600000 USD
CY2022Q1 base Number Of Short Term Investments In Unrealized Loss Position
NumberOfShortTermInvestmentsInUnrealizedLossPosition
25 investment
CY2022Q1 base Short Term Investments Estimated Fair Value
ShortTermInvestmentsEstimatedFairValue
71800000 USD
CY2022Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3817000 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4518000 USD
CY2022Q2 base Prepaid Software Current
PrepaidSoftwareCurrent
2779000 USD
CY2022Q1 base Prepaid Software Current
PrepaidSoftwareCurrent
2297000 USD
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1418000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1744000 USD
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8014000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8559000 USD
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11995000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11477000 USD
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7654000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7189000 USD
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4341000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4288000 USD
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
700000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
700000 USD
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2400000 USD
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5557000 USD
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
2546000 USD
CY2022Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
4226000 USD
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2515000 USD
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2863000 USD
CY2022Q2 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
564000 USD
CY2022Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
3497000 USD
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8025000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16143000 USD
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
939000 USD
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
717000 USD
CY2022Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
408000 USD
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
671000 USD
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
372000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
414000 USD
CY2022Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1227000 USD
CY2022Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1429000 USD
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2946000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3231000 USD
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
68466000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
69010000 USD
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2289000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2713000 USD
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
70755000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
71723000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
71723000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
61710000 USD
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-24207000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-22094000 USD
CY2022Q2 base Contract With Customer Liability Increase Due To Invoicing Prior To Satisfaction Of Performance Obligations
ContractWithCustomerLiabilityIncreaseDueToInvoicingPriorToSatisfactionOfPerformanceObligations
23239000 USD
CY2021Q2 base Contract With Customer Liability Increase Due To Invoicing Prior To Satisfaction Of Performance Obligations
ContractWithCustomerLiabilityIncreaseDueToInvoicingPriorToSatisfactionOfPerformanceObligations
17032000 USD
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
70755000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56648000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
169000000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
100700000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
200000 USD
CY2021Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.038
CY2019Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
400000 USD
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
600000 USD
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
200000 USD
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
661000 USD
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1509000 USD
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7668000 USD
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2717000 USD
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5627000 USD
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8344000 USD
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2225000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2911000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2461000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
680000 USD
CY2022Q2 base Lessee Operating Lease Liability To Be Paid After Year Four And Thereafter
LesseeOperatingLeaseLiabilityToBePaidAfterYearFourAndThereafter
597000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8874000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
530000 USD
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8344000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
2845000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
2638000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
2178000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Four Years
OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
362000 USD
CY2022Q1 base Operating Leases Future Minimum Payments Receivable In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsReceivableInFiveYearsAndThereafter
0 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
8023000 USD
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44537296 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44537296 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43847484 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43847484 shares
CY2022Q2 base Common Stock Number Of Vote
CommonStockNumberOfVote
1 vote
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16340420 shares
base Initial Offering Period Duration
InitialOfferingPeriodDuration
P24M
CY2022Q1 base Employee Stock Purchase Plan Initial Offering Number Of Purchase Periods
EmployeeStockPurchasePlanInitialOfferingNumberOfPurchasePeriods
4 purchasePeriod
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
283558 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
43.76
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2512511 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.79
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
53428 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
26.65
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2742641 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
22.13
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5450000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1829000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34853000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27955000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14599000 USD
CY2022Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2021Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1479000 USD
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19834000 USD
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19834000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16078000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16078000 USD
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44265000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44265000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6302000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6302000 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.55
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.55
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12804000 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36848000 shares

Files In Submission

Name View Source Status
0001845022-22-000057-index-headers.html Edgar Link pending
0001845022-22-000057-index.html Edgar Link pending
0001845022-22-000057.txt Edgar Link pending
0001845022-22-000057-xbrl.zip Edgar Link pending
base-20220430.htm Edgar Link pending
base-20220430.xsd Edgar Link pending
base-20220430x10qexhibit311.htm Edgar Link pending
base-20220430x10qexhibit312.htm Edgar Link pending
base-20220430x10qexhibit321.htm Edgar Link pending
base-20220430_cal.xml Edgar Link unprocessable
base-20220430_def.xml Edgar Link unprocessable
base-20220430_htm.xml Edgar Link completed
base-20220430_lab.xml Edgar Link unprocessable
base-20220430_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending